We are live on
!
Find out more
MYOK
MyoKardia, Inc. Common Stock
MYOK
MYOK
Delisted
MYOK was delisted on the 16th of November, 2020.
145 hedge funds and large institutions have $1.77B invested in MyoKardia, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 49 increasing their positions, 42 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
154% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 13
69% more call options, than puts
Call options by funds: $3.42M | Put options by funds: $2.03M
17% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 42
16% more funds holding
Funds holding: 125 → 145 (+20)
24% less capital invested
Capital invested by funds: $2.34B → $1.77B (-$562M)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
145
Holders Change
+20
Holders Change %
+16%
% of All Funds
3.23%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.11%
New
33
Increased
49
Reduced
42
Closed
13
Calls
$3.42M
Puts
$2.03M
Net Calls
+$1.39M
Net Calls Change
-$2.72M
Top Buyers
| 1 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$20.2M |
| 2 |
O
OrbiMed
New York
|
+$18.4M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
+$12.9M |
| 4 |
SC
Samlyn Capital
New York
|
+$10.1M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$6.68M |
